NASDAQ · Biotechnology

TNYA (TNYA) Stock

$0.77 -0.70% NASDAQ: TNYA Healthcare

Valuation

MetricValue
Price$0.77
Market Cap$167.00M
P/E Ratio-1.37
P/B Ratio1.09
P/S Ratio598.37
EPS (TTM)$-0.59
52-Week High$2.35
52-Week Low$0.53
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-73.98%
ROA-61.90%
ROCE-75.61%
Gross Margin1.45%
Operating Margin-381.59%
Net Margin-368.91%
Debt/Equity0.10
Current Ratio7.07

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-73.0M$-126.0M$-131.0M$-116.0M$-93.0M
Net Profit$-73.0M$-124.0M$-124.0M$-111.0M$-91.0M
EPS$-1.69$-2.76$-1.68$-1.31$-0.59
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$317.0M$279.0M$171.0M$120.0M$147.0M
Total Liabilities$38.0M$36.0M$31.0M$27.0M$24.0M
Cash$38.0M$95.0M$46.0M$4.0M$101.0M
Borrowings$16.0M$15.0M$12.0M$14.0M$11.0M

Latest News

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire · Jul 15, 2026 Tenaya Therapeutics Names Eric Hyllengren CFO MT Newswires · Jun 29, 2026 Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer GlobeNewswire · Jun 29, 2026 Exploring 3 High Growth Tech Stocks in US Market Simply Wall St. · Jun 15, 2026 Exploring High Growth Tech Stocks In The US Market Simply Wall St. · Jun 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-61.0M$-104.0M$-102.0M$-91.0M$-68.0M
Investing Cash Flow$-264.0M$63.0M$47.0M$0$55.0M
Financing Cash Flow$0$0$0$1.0M$0
Net Cash Flow$-90.0M$57.0M$-49.0M$-42.0M$96.0M
Free Cash Flow$-86.0M$-125.0M$-103.0M$-92.0M$-69.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-48.01%
Quick Ratio5.75
Interest Coverage—
Return 1Y21.66%
Return 3Y-84.24%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABEO $7.14 +3.48% 5.14 $406.94M 0.00%
CRBU $1.65 +0.61% -1.25 $163.65M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%
FHTXFoghorn Therapeutics Inc. $5.20 +7.22% -4.15 $305.31M 0.00%
HUMA $0.66 -1.79% -4.19 $110.81M 0.00%

About TNYA

TNYA is led by CEO Faraz Ali, employs 97 people, headquartered in US, publicly traded since 2021.

TNYA stock trades at $0.77 with a market capitalization of $167.00M. The stock is valued at a price-to-earnings (P/E) ratio of -1.37, price-to-book of 1.09, price-to-sales of 598.37. Over the past 52 weeks the stock has ranged between $0.53 and $2.35, and currently trades 67.2% below its 52-week high.

On profitability, TNYA generates a return on equity (ROE) of -73.98%, return on capital employed of -75.61%, an operating margin of -381.59%, a net profit margin of -368.91%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides